• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估膀胱肿瘤抗原检测作为犬下泌尿道移行细胞癌筛查检测的效果。

Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.

作者信息

Henry Carolyn J, Tyler Jeff W, McEntee Margaret C, Stokol Tracy, Rogers Kenita S, Chun Ruthanne, Garrett Laura D, McCaw Dudley L, Higginbotham Mary Lynn, Flessland Karen A, Stokes Pam Koffend

机构信息

Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.

出版信息

Am J Vet Res. 2003 Aug;64(8):1017-20. doi: 10.2460/ajvr.2003.64.1017.

DOI:10.2460/ajvr.2003.64.1017
PMID:12926595
Abstract

OBJECTIVE

To evaluate the veterinary version of the bladder tumor antigen (V-BTA) test as a screening test for transitional cell carcinoma (TCC) of the lower urinary tract of dogs.

ANIMALS

229 client-owned dogs.

PROCEDURE

Urine samples from dogs were shipped overnight to a single laboratory to facilitate testing within 48 hours of collection by use of the V-BTA rapid latex agglutination urine dipstick test. Groups of dogs included the following: 1) dogs with TCC of the lower urinary tract, 2) healthy control dogs, 3) unhealthy control dogs with non-TCC urinary tract disease, and 4) unhealthy control dogs without urinary tract disease. Test sensitivity and specificity were calculated by use of standard methods. Logistic models were developed to assess the effect of disease status, test conditions, urine composition, and signalment on the performance of the V-BTA test.

RESULTS

A total of 229 urine samples were analyzed, including 48 from dogs with suspected (n = 3) or confirmed (45) TCC. Test sensitivities were 88, 87, and 85% for all dogs with (suspected and confirmed) TCC, dogs with confirmed TCC at any site, and dogs with confirmed TCC of the urinary bladder, respectively. Test specificities were 84, 41, and 86% for healthy control dogs, unhealthy control dogs with non-TCC urinary tract disease, and unhealthy control dogs without urinary tract disease, respectively. The test performed slightly better on centrifuged urine samples than on uncentrifuged urine samples.

CONCLUSIONS AND CLINICAL RELEVANCE

Our results indicate that the V-BTA test is useful in screening for urinary tract TCC in dogs.

摘要

目的

评估兽用膀胱肿瘤抗原(V - BTA)检测作为犬下泌尿道移行细胞癌(TCC)筛查试验的效果。

动物

229只客户拥有的犬。

方法

将犬的尿液样本隔夜运送至单个实验室,以便在采集后48小时内使用V - BTA快速乳胶凝集尿试纸条检测进行检测。犬的分组如下:1)患有下泌尿道TCC的犬;2)健康对照犬;3)患有非TCC泌尿道疾病的非健康对照犬;4)无泌尿道疾病的非健康对照犬。采用标准方法计算检测的敏感性和特异性。建立逻辑模型以评估疾病状态、检测条件、尿液成分和特征对V - BTA检测性能的影响。

结果

共分析了229份尿液样本,其中48份来自疑似(n = 3)或确诊(45)TCC的犬。所有(疑似和确诊)患有TCC的犬、任何部位确诊患有TCC的犬以及膀胱确诊患有TCC的犬的检测敏感性分别为88%、87%和85%。健康对照犬、患有非TCC泌尿道疾病的非健康对照犬和无泌尿道疾病的非健康对照犬的检测特异性分别为84%、41%和86%。该检测在离心尿液样本上的表现略优于未离心的尿液样本。

结论及临床意义

我们的结果表明,V - BTA检测可用于犬泌尿道TCC的筛查。

相似文献

1
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.评估膀胱肿瘤抗原检测作为犬下泌尿道移行细胞癌筛查检测的效果。
Am J Vet Res. 2003 Aug;64(8):1017-20. doi: 10.2460/ajvr.2003.64.1017.
2
Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.评估尿液中的微卫星不稳定性用于诊断犬下尿路移行细胞癌。
J Vet Intern Med. 2010 Nov-Dec;24(6):1445-51. doi: 10.1111/j.1939-1676.2010.0617.x. Epub 2010 Oct 12.
3
Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.犬尿钙卫蛋白在患有下尿路或泌尿生殖道癌的犬中的诊断性能。
BMC Vet Res. 2017 Apr 21;13(1):112. doi: 10.1186/s12917-017-1032-5.
4
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.评估DD23作为膀胱癌病史患者复发性膀胱移行细胞癌检测标志物的价值。
Urology. 2003 Mar;61(3):539-43. doi: 10.1016/s0090-4295(02)02400-7.
5
Evaluation of a bladder tumor antigen test for the diagnosis of lower urinary tract malignancies in dogs.评估一种用于诊断犬下泌尿道恶性肿瘤的膀胱肿瘤抗原检测方法。
Am J Vet Res. 2002 Mar;63(3):370-3. doi: 10.2460/ajvr.2002.63.370.
6
Utility of the BTA stat test kit for bladder cancer screening.BTA stat检测试剂盒用于膀胱癌筛查的效用。
Diagn Cytopathol. 1999 Jul;21(1):27-9. doi: 10.1002/(sici)1097-0339(199907)21:1<27::aid-dc8>3.0.co;2-8.
7
Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.作为膀胱移行细胞癌标志物的尿中人补体因子H相关蛋白(BTA stat和BTA TRAK)以及细胞角蛋白8、18片段(UBC rapid和UBC IRMA)的定性和定量检测
Eur Urol. 2002 Jan;41(1):34-9. doi: 10.1016/s0302-2838(01)00015-x.
8
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
9
MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.利用血液和尿液样本对患有膀胱移行细胞癌的犬进行微小RNA分析。
BMC Vet Res. 2017 Nov 15;13(1):339. doi: 10.1186/s12917-017-1259-1.
10
[Clinical evaluation of the bladder tumor marker "Tu-MARK-BTA"].膀胱肿瘤标志物“Tu-MARK-BTA”的临床评估
Hinyokika Kiyo. 1991 Apr;37(4):335-9.

引用本文的文献

1
Vaginal swab cytology as a diagnostic tool for neoplasia of the lower urinary tract in 5 dogs.阴道拭子细胞学检查作为诊断下尿路肿瘤的工具在 5 只犬中的应用。
Can Vet J. 2022 Dec;63(12):1221-1225.
2
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma.用于高级别尿路上皮癌早期检测和干预研究的天然犬类模型的鉴定。
Front Oncol. 2022 Nov 11;12:1011969. doi: 10.3389/fonc.2022.1011969. eCollection 2022.
3
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
犬下尿路尿路上皮癌组织 S100/钙粒蛋白表达与血液中性粒细胞与淋巴细胞比值(NLR)。
BMC Vet Res. 2022 Nov 21;18(1):412. doi: 10.1186/s12917-022-03513-z.
4
Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.膀胱癌中的分子标志物:在诊断、预后和治疗中的应用
Vet Sci. 2022 Feb 28;9(3):107. doi: 10.3390/vetsci9030107.
5
Lower Urinary Tract Neoplasia.下尿路肿瘤
Vet Sci. 2018 Nov 27;5(4):96. doi: 10.3390/vetsci5040096.
6
Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.细胞外环磷酸腺苷依赖性蛋白激酶A自身抗体和C反应蛋白作为犬癌症诊断的血清生物标志物。
Vet Comp Oncol. 2019 Mar;17(1):99-106. doi: 10.1111/vco.12450. Epub 2018 Nov 28.
7
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq.RNA-Seq 对犬浸润性尿路上皮膀胱癌的综合基因表达分析。
BMC Cancer. 2018 Apr 27;18(1):472. doi: 10.1186/s12885-018-4409-3.
8
MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.利用血液和尿液样本对患有膀胱移行细胞癌的犬进行微小RNA分析。
BMC Vet Res. 2017 Nov 15;13(1):339. doi: 10.1186/s12917-017-1259-1.
9
Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.犬尿钙卫蛋白在患有下尿路或泌尿生殖道癌的犬中的诊断性能。
BMC Vet Res. 2017 Apr 21;13(1):112. doi: 10.1186/s12917-017-1032-5.
10
A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine.一种用于从犬尿液中诊断移行细胞癌的多重生物标志物方法。
Anal Biochem. 2014 Jun 15;455:41-7. doi: 10.1016/j.ab.2014.03.017. Epub 2014 Apr 2.